Bone marrow-derived mesenchymal stem cells for treatment of liver failure
The aim of this study is to assess whether treatment with allogeneic bone marrow-derived mesenchymal stem cells (BM-MSCs) can be effective against liver failure caused by the Hepatitis B Virus (HBV).
Read More
No additional information regarding the therapeutic cells was provided by the sponsor.
Read More
Product Information for
Bone marrow-derived mesenchymal stem cells for treatment of liver failure